Targeted delivery of mesoporous silica nanoparticles loaded monastrol into cancer cells: an in vitro study
Open Access
- 11 September 2017
- journal article
- research article
- Published by Springer Nature in Applied Nanoscience
- Vol. 7 (8) , 549-555
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Structure based virtual screening-driven identification of monastrol as a potent urease inhibitorJournal of Molecular Graphics and Modelling, 2013
- Mesoporous Silica Nanoparticles for Increasing the Oral Bioavailability and Permeation of Poorly Water Soluble DrugsMolecular Pharmaceutics, 2012
- Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed miceBiomaterials, 2011
- Assessment of uptake and toxicity of fluorescent silica nanoparticles in zebrafish (Danio rerio) early life stagesAquatic Toxicology, 2010
- Structure–Activity Relationships and Molecular Docking of Novel Dihydropyrimidine‐Based Mitotic Eg5 InhibitorsChemMedChem, 2010
- Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartanJournal of Controlled Release, 2010
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- Nanotechnology-based drug delivery systemsJournal of Occupational Medicine and Toxicology, 2007
- Mitotic drug targets and the development of novel anti-mitotic anticancer drugsDrug Resistance Updates, 2007
- The present and future of nanotechnology in human health careNanomedicine: Nanotechnology, Biology and Medicine, 2007